{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T06:51:50Z","timestamp":1782802310936,"version":"3.54.5"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jsbmb.2014.04.004","type":"journal-article","created":{"date-parts":[[2014,4,19]],"date-time":"2014-04-19T15:01:47Z","timestamp":1397919707000},"page":"172-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["The intracrinology of breast cancer"],"prefix":"10.1016","volume":"145","author":[{"given":"Keely May","family":"McNamara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.jsbmb.2014.04.004_bib0005","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/jnci\/94.19.1433","article-title":"Oophorectomy for breast cancer: history revisited","volume":"94","author":"Love","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.04.004_bib0010","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","volume":"78","author":"Labrie","year":"1991","journal-title":"Intracrinol. Mol. Cell Endocrinol."},{"issue":"8","key":"10.1016\/j.jsbmb.2014.04.004_bib0015","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/ijc.24132","article-title":"Does the increase of endogenous steroid hormone levels also affect breast cancer risk in Chinese women? A case-control study in Chongqing: China","volume":"124","author":"Wang","year":"2009","journal-title":"Int J Cancer"},{"issue":"19","key":"10.1016\/j.jsbmb.2014.04.004_bib0020","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/jnci\/djj376","article-title":"Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women","volume":"98","author":"Eliassen","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"10","key":"10.1016\/j.jsbmb.2014.04.004_bib0025","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/dji132","article-title":"Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"97","author":"Kaaks","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0030","doi-asserted-by":"crossref","first-page":"R32","DOI":"10.1186\/bcr3117","article-title":"Premenopausal serum androgens and breast cancer risk: a nested case-control study","volume":"14","author":"Zeleniuch-Jacquotte","year":"2012","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ijc.11034","article-title":"Plasma sex steroid hormones and breast cancer risk in Chinese women","volume":"105","author":"Yu","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0040","first-page":"45","article-title":"Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA)","volume":"15","author":"Sturgeon","year":"2004","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.jsbmb.2014.04.004_bib0045","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/bcr2779","article-title":"Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk","volume":"12","author":"Dorgan","year":"2010","journal-title":"Breast Cancer Res."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.04.004_bib0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ijc.20403","article-title":"Endogenous sex hormones and subsequent breast cancer in premenopausal women","volume":"112","author":"Micheli","year":"2004","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.jsbmb.2014.04.004_bib0055","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/bjc.1997.183","article-title":"A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey","volume":"75","author":"Thomas","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"3\u20135","key":"10.1016\/j.jsbmb.2014.04.004_bib0060","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jsbmb.2007.09.012","article-title":"Intracrinology of estrogens and androgens in breast carcinoma","volume":"108","author":"Sasano","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"11","key":"10.1016\/j.jsbmb.2014.04.004_bib0065","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1440-1827.2009.02444.x","article-title":"In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology","volume":"59","author":"Sasano","year":"2009","journal-title":"Pathol. Int."},{"issue":"3-5","key":"10.1016\/j.jsbmb.2014.04.004_bib0070","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jsbmb.2011.12.004","article-title":"The advantages of co-culture over mono cell culture in simulating in vivo environment","volume":"131","author":"Miki","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.04.004_bib0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1158\/0008-5472.657.65.2","article-title":"Interactions between prostaglandin E(2): liver receptor homologue-1, and aromatase in breast cancer","volume":"65","author":"Zhou","year":"2005","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.04.004_bib0080","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0046-8177(94)90127-9","article-title":"Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders","volume":"25","author":"Sasano","year":"1994","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.04.004_bib0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2001-0031","article-title":"Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone","volume":"24","author":"Labrie","year":"2003","journal-title":"Endocr. Rev."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.04.004_bib0090","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.mce.2010.11.001","article-title":"Steroid sulfatase and estrogen sulfotransferase in human carcinomas","volume":"340","author":"Suzuki","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"issue":"10","key":"10.1016\/j.jsbmb.2014.04.004_bib0095","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/j.1349-7006.2011.02018.x","article-title":"Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3beta, 17beta-diol","volume":"102","author":"Honma","year":"2011","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.04.004_bib0100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1006009031839","article-title":"Expression of 3beta-hydroxysteroid dehydrogenase-5,4-en isomerase activity by infiltrating ductal human breast carcinoma in vitro","volume":"50","author":"Gunasegaram","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/jme.0.0260011","article-title":"Immunoelectron microscopic localization of 3beta-hydroxysteroid dehydrogenase and type 5 17beta-hydroxysteroid dehydrogenase in the human prostate and mammary gland","volume":"26","author":"Pelletier","year":"2001","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1749-6632.2008.03682.x","article-title":"17beta-hydroxysteroid dehydrogenases in human breast cancer","volume":"1155","author":"Nagasaki","year":"2009","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.04.004_bib0115","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1054\/bjoc.1999.0956","article-title":"17Beta-hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters","volume":"82","author":"Suzuki","year":"2000","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.jsbmb.2014.04.004_bib0120","first-page":"4042","article-title":"Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma","volume":"81","author":"Sasano","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.04.004_bib0125","first-page":"2250","article-title":"5Alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions","volume":"86","author":"Suzuki","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0130","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-014-2942-6","article-title":"Androgenic pathways in the progression of triple negative breast carcinoma: a comparison between aggressive and non-aggressive subtypes","author":"McNamara","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"issue":"10","key":"10.1016\/j.jsbmb.2014.04.004_bib0135","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.humpath.2013.04.021","article-title":"Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer","volume":"44","author":"Shibahara","year":"2013","journal-title":"Hum. Pathol."},{"issue":"8","key":"10.1016\/j.jsbmb.2014.04.004_bib0140","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1210\/me.2012-1107","article-title":"Minireview: the androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?","volume":"26","author":"Hickey","year":"2012","journal-title":"Mol. Endocrinol."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.04.004_bib0145","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/cas.12121","article-title":"Androgenic pathway in triple negative invasive ductal tumours: its correlation with tumour cell proliferation","volume":"104","author":"McNamara","year":"2013","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0150","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12672-010-0062-2","article-title":"Increased 5alpha-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation","volume":"2","author":"Chanplakorn","year":"2011","journal-title":"Horm. Cancer"},{"issue":"2","key":"10.1016\/j.jsbmb.2014.04.004_bib0155","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.22317","article-title":"5\u03b1-Reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production","volume":"120","author":"Suzuki","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0160","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/ERC-07-0092","article-title":"Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast","volume":"15","author":"Shibuya","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"issue":"6B","key":"10.1016\/j.jsbmb.2014.04.004_bib0165","doi-asserted-by":"crossref","first-page":"E51","DOI":"10.1111\/j.1365-2559.2012.04214.x","article-title":"Expression of 5alpha-reductase in apocrine carcinoma of the breast and its correlation with clinicopathological aggressiveness","volume":"60","author":"Kasashima","year":"2012","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.jsbmb.2014.04.004_bib0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1210\/er.2008-0016","article-title":"History of aromatase: saga of an important biological mediator and therapeutic target","volume":"30","author":"Santen","year":"2009","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.04.004_bib0175","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0960-0760(90)90465-W","article-title":"Relationship between tumour aromatase activity: tumour characteristics and response to therapy","volume":"37","author":"Miller","year":"1990","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5B","key":"10.1016\/j.jsbmb.2014.04.004_bib0180","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0960-0760(91)90026-2","article-title":"Aromatase activity in breast tissue","volume":"39","author":"Miller","year":"1991","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"10","key":"10.1016\/j.jsbmb.2014.04.004_bib0185","first-page":"2588","article-title":"Intratumoral aromatase as a prognostic factor in human breast carcinoma","volume":"49","author":"Silva","year":"1989","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.jsbmb.2014.04.004_bib0190","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1002\/1097-0142(19921001)70:7<1951::AID-CNCR2820700723>3.0.CO;2-#","article-title":"Prognostic value of breast cancer aromatase","volume":"70","author":"Lipton","year":"1992","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/pin.12015","article-title":"Immunohistochemical analysis of aromatase in metastatic lymph nodes of breast cancer","volume":"63","author":"Shibahara","year":"2013","journal-title":"Pathol. Int."},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0200","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fendo.2013.00116","article-title":"Phase Two Steroid Metabolism and Its Roles in Breast and Prostate Cancer Patients","volume":"4","author":"McNamara","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"11","key":"10.1016\/j.jsbmb.2014.04.004_bib0205","first-page":"2762","article-title":"Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma","volume":"63","author":"Suzuki","year":"2003","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00432-007-0249-2","article-title":"Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer","volume":"134","author":"Hudelist","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3-5","key":"10.1016\/j.jsbmb.2014.04.004_bib0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsbmb.2008.12.008","article-title":"Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients","volume":"113","author":"Suzuki","year":"2009","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"21","key":"10.1016\/j.jsbmb.2014.04.004_bib0220","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1073\/pnas.162477299","article-title":"An endocrine pathway in the prostate: ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth","volume":"99","author":"Weihua","year":"2002","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-013-2788-3","article-title":"Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers","volume":"143","author":"Hanamura","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0230","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsbmb.2003.10.011","article-title":"The proliferative effects of 5-androstene-3 beta,17 beta-diol and 5 alpha-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines","volume":"88","author":"Aspinall","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1210\/jcem-59-1-29","article-title":"In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway","volume":"59","author":"Santner","year":"1984","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.04.004_bib0240","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10549-010-0785-3","article-title":"Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients","volume":"120","author":"Chanplakorn","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"issue":"6162","key":"10.1016\/j.jsbmb.2014.04.004_bib0245","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.1241908","article-title":"27-hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology","volume":"342","author":"Nelson","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.04.004_bib0250","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1677\/erc.1.01010","article-title":"Progesterone metabolites in breast cancer","volume":"13","author":"Wiebe","year":"2006","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2407-3-9","article-title":"Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells","volume":"3","author":"Wiebe","year":"2003","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2407-4-27","article-title":"Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma","volume":"4","author":"Lewis","year":"2004","journal-title":"BMC Cancer"},{"issue":"7","key":"10.1016\/j.jsbmb.2014.04.004_bib0265","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.5858\/134.7.e48","article-title":"American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version)","volume":"134","author":"Hammond","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"4","key":"10.1016\/j.jsbmb.2014.04.004_bib0270","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/bjc.1971.85","article-title":"Oestradiol receptors in carcinoma and benign disease of the breast: an in vitro assay","volume":"25","author":"Feherty","year":"1971","journal-title":"Br. J. Cancer"},{"issue":"8","key":"10.1016\/j.jsbmb.2014.04.004_bib0275","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/annonc\/mdr304","article-title":"Strategies for subtypes\u2014dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011","volume":"22","author":"Goldhirsch","year":"2011","journal-title":"Ann. Oncol."},{"issue":"19","key":"10.1016\/j.jsbmb.2014.04.004_bib0280","doi-asserted-by":"crossref","first-page":"10869","DOI":"10.1073\/pnas.191367098","article-title":"Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications","volume":"98","author":"Sorlie","year":"2001","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"29","key":"10.1016\/j.jsbmb.2014.04.004_bib0285","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1038\/sj.onc.1208561","article-title":"Identification of molecular apocrine breast tumours by microarray analysis","volume":"24","author":"Farmer","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.jsbmb.2014.04.004_bib0290","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01806453","article-title":"Estrogen receptor status as a prognostic indicator for stage I breast cancer patients","volume":"2","author":"Crowe","year":"1982","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0295","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/msb.2011.59","article-title":"Cellular reprogramming by the conjoint action of ERalpha, FOXA1, and GATA3 to a ligand-inducible growth state","volume":"7","author":"Kong","year":"2011","journal-title":"Mol. Syst. Biol."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.04.004_bib0300","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/ijc.22389","article-title":"FOXA1: growth inhibitor and a favorable prognostic factor in human breast cancer","volume":"120","author":"Wolf","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"12","key":"10.1016\/j.jsbmb.2014.04.004_bib0305","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1242\/dev.043299","article-title":"FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis","volume":"137","author":"Bernardo","year":"2010","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.jsbmb.2014.04.004_bib0310","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.humpath.2013.05.022","article-title":"Significance of GATA-3 expression in outcomes of patients with breast cancer who received systemic chemotherapy and\/or hormonal therapy and clinicopathologic features of GATA-3-positive tumors","volume":"44","author":"Gulbahce","year":"2013","journal-title":"Hum. Pathol."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0315","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1200\/JCO.2003.03.088","article-title":"Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998","volume":"21","author":"Li","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"30","key":"10.1016\/j.jsbmb.2014.04.004_bib0320","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1200\/JCO.2005.09.004","article-title":"Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy","volume":"23","author":"Cui","year":"2005","journal-title":"J. Clin. Oncol."},{"issue":"17","key":"10.1016\/j.jsbmb.2014.04.004_bib0325","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/jnci\/dji249","article-title":"Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance","volume":"97","author":"Arpino","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0330","series-title":"Understanding estrogen receptor transcription in breast cancer","author":"Carroll","year":"2013"},{"issue":"4","key":"10.1016\/j.jsbmb.2014.04.004_bib0335","first-page":"434","article-title":"Androgen receptor as a targeted therapy for breast cancer","volume":"2","author":"Garay","year":"2012","journal-title":"Am. J. Cancer Res."},{"issue":"7","key":"10.1016\/j.jsbmb.2014.04.004_bib0340","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0345","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jsbmb.2012.08.007","article-title":"Androgen receptor in triple negative breast cancer","volume":"133","author":"McNamara","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-009-0436-8","article-title":"Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells","volume":"121","author":"De Amicis","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0355","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ccr.2011.05.026","article-title":"Targeting androgen receptor in estrogen receptor-negative breast cancer","volume":"20","author":"Ni","year":"2011","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.jsbmb.2014.04.004_bib0360","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1101\/gad.209569.112","article-title":"Amplitude modulation of androgen signaling by c-MYC","volume":"27","author":"Ni","year":"2013","journal-title":"Genes Dev."},{"issue":"42","key":"10.1016\/j.jsbmb.2014.04.004_bib0365","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1038\/onc.2011.144","article-title":"Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers","volume":"30","author":"Wang","year":"2011","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.jsbmb.2014.04.004_bib0370","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/hmg\/ddt077","article-title":"Androgen receptor-induced tumor suppressor: KLLN, inhibits breast cancer growth and transcriptionally activates p53\/p73-mediated apoptosis in breast carcinomas","volume":"22","author":"Wang","year":"2013","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.jsbmb.2014.04.004_bib0375","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0039-128X(02)00047-8","article-title":"Human oestrogen receptors: differential expression of ER alpha and beta and the identification of ER beta variants","volume":"67","author":"Scobie","year":"2002","journal-title":"Steroids"},{"issue":"3","key":"10.1016\/j.jsbmb.2014.04.004_bib0380","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1023\/A:1014465916473","article-title":"Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines","volume":"71","author":"Tong","year":"2002","journal-title":"Breast Cancer Res. Treat."},{"issue":"22","key":"10.1016\/j.jsbmb.2014.04.004_bib0385","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1200\/JCO.2007.14.2968","article-title":"Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy","volume":"26","author":"Honma","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"1\u20133","key":"10.1016\/j.jsbmb.2014.04.004_bib0390","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cbi.2008.10.024","article-title":"Type 5 17beta-hydroxysteroid dehydrogenase\/prostaglandin F synthase (AKR1C3): role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs","volume":"178","author":"Byrns","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"28","key":"10.1016\/j.jsbmb.2014.04.004_bib0395","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1200\/JCO.2009.27.2419","article-title":"Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers","volume":"28","author":"Bianchini","year":"2010","journal-title":"J. Clin. Oncol."},{"issue":"1\u20135","key":"10.1016\/j.jsbmb.2014.04.004_bib0400","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jsbmb.2007.05.007","article-title":"Controversies of aromatase localization in human breast cancer\u2014stromal versus parenchymal cells","volume":"106","author":"Miki","year":"2007","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.04.004_bib0405","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/bcr3410","article-title":"HIF-1alpha stimulates aromatase expression driven by prostaglandin E2 in breast adipose stroma","volume":"15","author":"Samarajeewa","year":"2013","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0410","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10549-013-2716-6","article-title":"Distinct nuclear receptor expression in stroma adjacent to breast tumors","volume":"142","author":"Knower","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0415","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1749-6632.2008.03683.x","article-title":"New developments in intracrinology of human breast cancer: estrogen sulfatase and sulfotransferase","volume":"1155","author":"Sasano","year":"2009","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"3-5","key":"10.1016\/j.jsbmb.2014.04.004_bib0420","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0960-0760(03)00356-X","article-title":"Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma","volume":"86","author":"Suzuki","year":"2003","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0425","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0076-6879(05)00018-2","article-title":"Analysis for localization of steroid sulfatase in human tissues","volume":"400","author":"Suzuki","year":"2005","journal-title":"Methods Enzymol."},{"issue":"3","key":"10.1016\/j.jsbmb.2014.04.004_bib0430","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ijc.2910500310","article-title":"Immunological analysis of 17 beta-hydroxysteroid dehydrogenase in benign and malignant human breast tissue","volume":"50","author":"Poutanen","year":"1992","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jsbmb.2014.04.004_bib0435","doi-asserted-by":"crossref","first-page":"e724","DOI":"10.1038\/cddis.2013.235","article-title":"DAX-1, as an androgen-target gene, inhibits aromatase expression: a novel mechanism blocking estrogen-dependent breast cancer cell proliferation","volume":"4","author":"Lanzino","year":"2013","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.jsbmb.2014.04.004_bib0440","first-page":"229","article-title":"Multiple signaling pathways mediate interleukin-4-induced 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase type 1 gene expression in human breast cancer cells","volume":"14","author":"Gingras","year":"2000","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0445","first-page":"66","article-title":"Induction of 3beta-hydroxysteroid dehydrogenase\/delta5-delta4 isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13","volume":"13","author":"Gingras","year":"1999","journal-title":"Mol. Endocrinol."},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0450","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ijc.2910420122","article-title":"Paracrine influence of human breast stromal fibroblasts on breast epithelial cells: secretion of a polypeptide which stimulates reductive 17 beta-oestradiol dehydrogenase activity","volume":"42","author":"Adams","year":"1988","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.jsbmb.2014.04.004_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/jme.0.0250001","article-title":"Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease","volume":"25","author":"Labrie","year":"2000","journal-title":"J. Mol. Endocrinol."},{"issue":"4-5","key":"10.1016\/j.jsbmb.2014.04.004_bib0460","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jsbmb.2008.10.004","article-title":"Expression of 17beta-hydroxysteroid dehydrogenase type 2 and type 5 in breast cancer and adjacent non-malignant tissue: a correlation to clinicopathological parameters","volume":"112","author":"Han","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5","key":"10.1016\/j.jsbmb.2014.04.004_bib0465","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/ijc.1525","article-title":"Involvement of up-regulation of 17beta-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers","volume":"94","author":"Miyoshi","year":"2001","journal-title":"Int. J. Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jsbmb.2014.04.004_bib0470","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1023\/A:1006029612990","article-title":"Aromatase expression in the human breast","volume":"49","author":"Brodie","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.jsbmb.2014.04.004_bib0475","first-page":"2537","article-title":"Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors","volume":"61","author":"Roger","year":"2001","journal-title":"Cancer Res."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076014000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076014000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T23:49:13Z","timestamp":1760744953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076014000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":95,"alternative-id":["S0960076014000909"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.04.004","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The intracrinology of breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2014.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}